Cofetuzumab Pelidotin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Cofetuzumab Pelidotin, covering 2026-03-24 to 2026-03-24. Get the full timeline:
Most recent: Clinical Trial Update: An Efficacy and Safety Study of Cofetuzumab Pelidotin in Participants With PTK7-Expressing, Recurrent Non-Small Cell Lung Cancer [Phase 1]